Shimada M - Search Results

1

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.

Harter P, Johnson T, Berton-Rigaud D, Park SY, Friedlander M, Del Campo JM, Shimada M, Forget F, Mirza MR, Colombo N, Zamagni C, Chan JK, Imhof M, Herzog TJ, O'Donnell D, Heitz F, King K, Stinnett S, Barrett C, Jobanputra M, Xu CF, du Bois A. Harter P, et al. Among authors: shimada m. Gynecol Oncol. 2016 Mar;140(3):443-9. doi: 10.1016/j.ygyno.2015.12.027. Epub 2015 Dec 29. Gynecol Oncol. 2016. PMID: 26740259 Clinical Trial.

2

Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.

Okada M, Kigawa J, Minagawa Y, Kanamori Y, Shimada M, Takahashi M, Oishi T, Terakawa N. Okada M, et al. Among authors: shimada m. Gynecol Oncol. 1998 Jul;70(1):61-4. doi: 10.1006/gyno.1998.5005. Gynecol Oncol. 1998. PMID: 9698475 Clinical Trial.

3

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Takahashi M, Kigawa J, Oishi T, Itamochi H, Shimada M, Sato S, Kamazawa S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: shimada m. Gynecol Obstet Invest. 2000;49(3):204-8. doi: 10.1159/000010247. Gynecol Obstet Invest. 2000. PMID: 10729763

4

Alteration of a p53 gene status affects outcome of patients with recurrent ovarian cancer.

Irie T, Kigawa J, Minagawa Y, Oishi T, Takahashi M, Shimada M, Kamazawa S, Sato S, Terakawa N. Irie T, et al. Among authors: shimada m. Oncology. 2000 Apr;58(3):237-41. doi: 10.1159/000012106. Oncology. 2000. PMID: 10765126

5

Cellular efflux pump and interaction between cisplatin and paclitaxel in ovarian cancer cells.

Kamazawa S, Kigawa J, Minagawa Y, Itamochi H, Shimada M, Takahashi M, Sato S, Akeshima R, Terakawa N. Kamazawa S, et al. Among authors: shimada m. Oncology. 2000 Nov;59(4):329-35. doi: 10.1159/000012191. Oncology. 2000. PMID: 11096346

6

Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.

Kigawa J, Sato S, Shimada M, Kanamori Y, Itamochi H, Terakawa N. Kigawa J, et al. Among authors: shimada m. Gynecol Oncol. 2002 Feb;84(2):210-5. doi: 10.1006/gyno.2001.6488. Gynecol Oncol. 2002. PMID: 11812076

7

Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman.

Tagashira Y, Shimada M, Kigawa J, Iba T, Terakawa N. Tagashira Y, et al. Among authors: shimada m. Gynecol Oncol. 2003 Dec;91(3):643-7. doi: 10.1016/j.ygyno.2003.08.005. Gynecol Oncol. 2003. PMID: 14675692

8

Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.

Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N. Shimada M, et al. Gynecol Oncol. 2004 Jun;93(3):628-31. doi: 10.1016/j.ygyno.2004.03.011. Gynecol Oncol. 2004. PMID: 15196855 Clinical Trial.

9

The benefit of chemotherapy in a patient with multiple brain metastases and meningitis carcinomatosa from ovarian cancer.

Watanabe A, Shimada M, Kigawa J, Iba T, Oishi T, Kanamori Y, Terakawa N. Watanabe A, et al. Among authors: shimada m. Int J Clin Oncol. 2005 Feb;10(1):69-71. doi: 10.1007/s10147-004-0437-x. Int J Clin Oncol. 2005. PMID: 15729605

10

Ovarian metastasis in carcinoma of the uterine cervix.

Shimada M, Kigawa J, Nishimura R, Yamaguchi S, Kuzuya K, Nakanishi T, Suzuki M, Kita T, Iwasaka T, Terakawa N. Shimada M, et al. Gynecol Oncol. 2006 May;101(2):234-7. doi: 10.1016/j.ygyno.2005.10.004. Epub 2005 Nov 21. Gynecol Oncol. 2006. PMID: 16300819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,274 results

Search Page

Filters